TBPH Stock Summary and Trading Ideas (Theravance Biopharma - | NASDAQ:TBPH)

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

What symbol and exchange does Theravance Biopharma - shares trade?

Theravance Biopharma - trades on the NASDAQ stock market under the symbol TBPH.

What is Theravance Biopharma - stock price doing today?

As of December 31, 2025, TBPH stock price declined to $18.71 with 477,524 million shares trading.

What is Theravance Biopharma -'s Beta?

TBPH has a beta of 1.11, meaning it tends to be more sensitive to market movements. TBPH has a correlation of 0.16 to the broad based SPY ETF.

How much is Theravance Biopharma - worth?

TBPH has a market cap of $948.08 million. This is considered a Small Cap stock.

How much money does Theravance Biopharma - make?

Last quarter Theravance Biopharma - reported $20 million in Revenue and $.07 earnings per share. This beat revenue expectation by $221,900 and exceeded earnings estimates by $.15.

What is the highest and lowest price Theravance Biopharma - traded in the last 3 year period?

In the last 3 years, TBPH traded as high as $20.33 and as low as $7.44.

What are the top ETFs holding Theravance Biopharma -?

The top ETF exchange traded funds that TBPH belongs to (by Net Assets): VTI, IWM, VXF, IBB, CALF.

Is Theravance Biopharma - (TBPH) a good investment?

TBPH has outperformed the market in the last year with a price return of +97.6% while the SPY ETF gained +17.2%. TBPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +28.2% and +6.7%, respectively, while the SPY returned +2.7% and +0.7%, respectively.

What are the support and resistance levels for Theravance Biopharma - (TBPH)?

TBPH support price is $18.46 and resistance is $19.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBPH shares will trade within this expected range on the day.